178 related articles for article (PubMed ID: 30255549)
41. Effect of intracellular folate concentration on the modulation of 5-fluorouracil cytotoxicity by the elevation of phosphoribosylpyrophosphate in cultured human KB cells.
Kane MA; Roth E; Raptis G; Schreiber C; Waxman S
Cancer Res; 1987 Dec; 47(24 Pt 1):6444-50. PubMed ID: 2445472
[TBL] [Abstract][Full Text] [Related]
42. Effects of uridine diphosphoglucose (UDPG) infusion on 5-phosphoribosyl pyrophosphate (PRPP) levels of mouse tissues.
Yip LC; Xu YL; Balis ME
Biochem Pharmacol; 1987 Mar; 36(5):633-7. PubMed ID: 2435292
[TBL] [Abstract][Full Text] [Related]
43. Arts syndrome is caused by loss-of-function mutations in PRPS1.
de Brouwer AP; Williams KL; Duley JA; van Kuilenburg AB; Nabuurs SB; Egmont-Petersen M; Lugtenberg D; Zoetekouw L; Banning MJ; Roeffen M; Hamel BC; Weaving L; Ouvrier RA; Donald JA; Wevers RA; Christodoulou J; van Bokhoven H
Am J Hum Genet; 2007 Sep; 81(3):507-18. PubMed ID: 17701896
[TBL] [Abstract][Full Text] [Related]
44. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
Sperling O; Boer P; Brosh S; Zoref E; de Vries A
Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
[TBL] [Abstract][Full Text] [Related]
45. A comparison of 5-fluorouracil metabolism in human colorectal cancer and colon mucosa.
Peters GJ; van Groeningen CJ; Laurensse EJ; Pinedo HM
Cancer; 1991 Nov; 68(9):1903-9. PubMed ID: 1717130
[TBL] [Abstract][Full Text] [Related]
46. The PRPP synthetase spectrum: what does it demonstrate about nucleotide syndromes?
Duley JA; Christodoulou J; de Brouwer AP
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1129-39. PubMed ID: 22132967
[TBL] [Abstract][Full Text] [Related]
47. Point mutations in PRPS1, the gene encoding the PRPP synthetase (PRS) 1 isoform, underlie X-linked PRS superactivity associated with purine nucleotide inhibitor-resistance.
Becker MA; Nosal JM; Switzer RL; Smith PR; Palella TD; Roessler BJ
Adv Exp Med Biol; 1994; 370():707-10. PubMed ID: 7661003
[No Abstract] [Full Text] [Related]
48. Phosphoribosylpyrophosphate Synthetase 1 Knockdown Suppresses Tumor Formation of Glioma CD133+ Cells Through Upregulating Cell Apoptosis.
Li C; Yan Z; Cao X; Zhang X; Yang L
J Mol Neurosci; 2016 Oct; 60(2):145-56. PubMed ID: 27343059
[TBL] [Abstract][Full Text] [Related]
49. Activation pathways of 5-fluorouracil in rat organs and in PC12 cells.
Mascia L; Ipata PL
Biochem Pharmacol; 2001 Jul; 62(2):213-8. PubMed ID: 11389880
[TBL] [Abstract][Full Text] [Related]
50. Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.
Kemeny NE; Ahmed T; Michaelson RA; Harper HD; Yip LC
J Clin Oncol; 1984 Apr; 2(4):311-5. PubMed ID: 6200577
[TBL] [Abstract][Full Text] [Related]
51. Inherited disorders of purine metabolism--underlying molecular mechanisms.
Gutensohn W
Klin Wochenschr; 1984 Oct; 62(20):953-62. PubMed ID: 6209448
[TBL] [Abstract][Full Text] [Related]
52. Pathways for alpha-D-ribose utilization for nucleobase salvage and 5-fluorouracil activation in rat brain.
Barsotti C; Ipata PL
Biochem Pharmacol; 2002 Jan; 63(2):117-22. PubMed ID: 11841784
[TBL] [Abstract][Full Text] [Related]
53. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
Elliott WL; Howard CT; Dykes DJ; Leopold WR
Cancer Res; 1989 Oct; 49(20):5586-90. PubMed ID: 2477146
[TBL] [Abstract][Full Text] [Related]
54. Human PRPS1 filaments stabilize allosteric sites to regulate activity.
Hvorecny KL; Hargett K; Quispe JD; Kollman JM
Nat Struct Mol Biol; 2023 Mar; 30(3):391-402. PubMed ID: 36747094
[TBL] [Abstract][Full Text] [Related]
55. Tiazofurin enhances the anabolism and toxicity of 5-fluorouracil.
Cysyk RL; Chisena CA; Hyman R; Monks A
Cancer Lett; 1996 Dec; 109(1-2):49-55. PubMed ID: 9020902
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
Inaba M; Naoe Y; Mitsuhashi J
Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
[TBL] [Abstract][Full Text] [Related]
57. [PRPS1 Expression in Children with Acute Leukemia and Its Clinical Significance].
Ma YM; An XZ; Guan XM; Kong QL; Li PF; Xian Y; Xiao JW; Meng Y; Liang SY; Yu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):311-317. PubMed ID: 28446267
[TBL] [Abstract][Full Text] [Related]
58. Wild-type and feedback-resistant phosphoribosyl pyrophosphate synthetases from Bacillus amyloliquefaciens: purification, characterization, and application to increase purine nucleoside production.
Zakataeva NP; Romanenkov DV; Skripnikova VS; Vitushkina MV; Livshits VA; Kivero AD; Novikova AE
Appl Microbiol Biotechnol; 2012 Mar; 93(5):2023-33. PubMed ID: 22083279
[TBL] [Abstract][Full Text] [Related]
59. Combinational treatment of 5-fluorouracil and casticin induces apoptosis in mouse leukemia WEHI-3 cells in vitro.
Cheng ZY; Chueh FS; Peng SF; Lin CH; Kuo CL; Huang WW; Chen PY; Way TD; Chung JG
Environ Toxicol; 2020 Sep; 35(9):911-921. PubMed ID: 32270916
[TBL] [Abstract][Full Text] [Related]
60. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
Romanini A; Li WW; Colofiore JR; Bertino JR
J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
